CryoLife To Present at U.S. Bancorp Piper Jaffray Health Care Conference in New York

ATLANTA, Ga., Jan. 27 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and bio-surgical device company, is scheduled to participate in the 16th Annual U.S. Bancorp Piper Jaffray Health Care Conference at the Pierre Hotel in New York City on Thursday, January 29, 2004.

Steven G. Anderson, CryoLife's President and CEO, will deliver the Company's presentation beginning at approximately 12:30 p.m. (Eastern).

To listen to a live web cast of the U.S. Bancorp Piper Jaffray conference, please visit the website http://www.talkpoint.com/viewer/starthere.asp?pres=104860 . CryoLife's presentation may also be accessed through its website, www.cryolife.com , on the Investor Relations page. An archived copy of the presentation will be available for thirty days on the websites mentioned above.

Founded in 1984, CryoLife, Inc. is a leader in the processing and distribution of implantable living human tissues for use in cardiovascular and vascular surgeries throughout the United States and Canada. The Company's BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels and is CE marked in the European Community and approved in Canada for use in soft tissue repair and approved in Australia for use in vascular and pulmonary sealing and repair. The Company also manufactures the SynerGraft(R) Vascular Graft, which is CE marked for distribution within the European Community.

For additional information about the company, visit CryoLife's web site: http://www.cryolife.com .

     Contact:  Joseph T. Schepers
               Vice President, Corporate Communications
               (770) 419-3355